Muc2-2A-CreERT2-IRES-tdTomato
Nomenclature
C57BL/6JSmo-Muc2em1(2A-CreERT2-tdTomato-Wpre-pA)Smoc
Cat. NO.
NM-KI-200301
Strain State
Repository Live
Gene Summary
Gene Symbol
Muc2
Model Description
Validation Data
Fig 1. Active tdTomato expression was observed in the large intestine of Muc2CreERT2-IRES-tdTomato/+ mouse. WT, wild type as control.
Fig 2. Active tdTomato expression was observed in the small intestine of Muc2CreERT2-IRES-tdTomato/+ mouse. WT, wild type as control.
Fig 3. No obvious tdTomato signal was observed in the stomach of Muc2CreERT2-IRES-tdTomato/+ mouse. WT, wild type as control.
Fig 4. Active tdTomato signal was observed in the colon of Muc2CreERT2-IRES-tdTomato/+ mouse. WT, wild type as control.
Fig 5. Active tdTomato signal was observed in the cecum of Muc2CreERT2-IRES-tdTomato/+ mouse. WT, wild type as control.
Fig 6. TdTomato signal was observed in the small intestine of Muc2CreERT2-IRES-tdTomato/+ mouse.WT, wild type as control.
Fig 7. No obvious tdTomato signal was observed in the stomach of Muc2CreERT2-IRES-tdTomato/+ mouse. WT, wild type as control.
Fig8. CreERT2 mediated recombination in colon of Muc2CreERT2-IRES-tdTomato/+; Rosa26zsGreen/+ mouse.
Fig9. Detection of tdTomato(red) and zsGreen(green) in various tissues of Muc2CreERT2-IRES-tdTomato/+; Rosa26zsGreen/+ mouse. Following tamoxifen induction, zsGreen expression was observed in the stomach, large intestine, small intestine, and thymus. that tdTomato was expressed in the stomach, large intestine, and small intestine.(57-days old, male) (For more detailed information please contact our technical advisor.)
You may also like
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreWorkshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
